The genetics of schizophrenia: glutamate not dopamine?

被引:76
作者
Collier, DA
Li, T
机构
[1] Inst Psychiat, Mol Genet Sect, Div Psychol Med, London SE5 8AF, England
[2] Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, London SE5 8AF, England
[3] Sichuan Univ, W China Hosp, Dept Psychiat, Chengdu 610041, Sichuan, Peoples R China
关键词
psychosis; linkage; association; genetic; 5-HT; (5-hydroxytryptmamine; serotonin); proline; neuregulin;
D O I
10.1016/j.ejphar.2003.08.105
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The major targets of current drugs used in mental health, such as neurotransmitter receptors and transporters, are based on serendipitous findings from several decades ago, and there is currently a severe drought of new drug targets. There is a pressing need for novel drugs, and much hope has been placed on the use of molecular genetics to help define them. However, despite evidence for a genetic basis to schizophrenia stretching back for over a century, and a heritability of about 80%, the identification of susceptibility genes has been an uphill struggle. Candidate gene studies, which have generally focussed on obvious candidates from the dopamine and scrotonin systems, as well as genes involved in brain development, have not generally been successful, although meta-analysis indicates that the dopamine D3 receptor gene (DRD3) and the serotonin receptor gene type 2A (HTR2A) may have a very small influence on risk. Linkage analysis has provided robust evidence of genetic loci, for example, on chromosomes 8p, 13q and 22q, and also implies shared genetic aetiology with bipolar disorder. The identification of these loci together with advances in genetic technology, especially the characterisation of polymorphisms, the understanding of haplotypes and the development of statistical methods, has lead to the identification of several plausible susceptibility genes, including neuregulin 1, proline dehydrogenase and dysbindin. Interestingly, these genes point more towards a role for the glutamate pathway rather than the dopamine pathway in schizophrenia. We have attempted to replicate some of these findings in schizophrenic patients from SW China, and we find significant association with a novel neuregulin 1 haplotype, with proline dehydrogenase polymorphisms, but not with catechol-O-methyltransferase (COMT). The replication of neuregulin 1 association on chromosome 8p by several investigators is the most convincing to date, and the presence of a syndrome similar to dementia praecox of 8p, linked families, and the lack of linkage of bipolar disorder to this region is a testament to the ideas of Kraepelin more than 100 years ago. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:177 / 184
页数:8
相关论文
共 63 条
[1]   Dementia praecox to schizophrenia: The first 100 years [J].
Adityanjee ;
Aderibigbe, YA ;
Theodoridis, D ;
Vieweg, WVR .
PSYCHIATRY AND CLINICAL NEUROSCIENCES, 1999, 53 (04) :437-448
[2]   Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia [J].
Badner, JA ;
Gershon, ES .
MOLECULAR PSYCHIATRY, 2002, 7 (04) :405-411
[3]   A prospective cohort study of childhood behavioral deviance and language abnormalities as predictors of adult schizophrenia [J].
Bearden, CE ;
Rosso, IM ;
Hollister, JM ;
Sanchez, LE ;
Hadley, T ;
Cannon, TD .
SCHIZOPHRENIA BULLETIN, 2000, 26 (02) :395-410
[4]   Are schizophrenic and bipolar disorders related? A review of family and molecular studies [J].
Berrettini, WH .
BIOLOGICAL PSYCHIATRY, 2000, 48 (06) :531-538
[5]  
Bleuler M., 1978, SCHIZOPHRENIC DISORD
[6]   A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain [J].
Bray, NJ ;
Buckland, PR ;
Williams, NM ;
Williams, HJ ;
Norton, N ;
Owen, MJ ;
O'Donovan, MC .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (01) :152-161
[7]   Neuregulin and ErbB receptor signaling pathways in the nervous system [J].
Buonanno, A ;
Fischbach, GD .
CURRENT OPINION IN NEUROBIOLOGY, 2001, 11 (03) :287-296
[8]  
Burke JG, 1996, AM J MED GENET, V67, P239, DOI 10.1002/(SICI)1096-8628(19960531)67:3<239::AID-AJMG1>3.0.CO
[9]  
2-I
[10]  
Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO